01/24/23 9:30 AMNasdaq : CODX covid-19Co-Diagnostics, Inc. Commemorates Third Anniversary of the Completion of its First COVID-19 Test DesignCo-Diagnostics also announced today that it would be hosting a booth at the upcoming BioHive and BioUtah Life Sciences Day on the Hill, on January 27, 2023 from 11:00 AM to 2:00 PM at the Utah State Capitol rotunda. The annual event showcases Utah's life sciences industry as one of the fastest growing in the nation, and the Company's booth is expected to...RHEA-AIneutral
01/05/23 9:30 AMNasdaq : CODX conferencesCo-Diagnostics, Inc. to Host Booth at CES 2023 January 5-8Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth this week at the 2023RHEA-AIneutral
11/30/22 10:00 AMNasdaq : CODX conferencesCo-Diagnostics, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference on December 1, 2022Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting on December 1,RHEA-AIneutral
11/14/22 9:30 AMNasdaq : CODX conferencesCo-Diagnostics, Inc. to Host Booth at MEDICA 2022 Trade Fair in Düsseldorf, GermanyCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth this week at theRHEA-AIneutral
11/10/22 4:13 PMNasdaq : CODX earningsCo-Diagnostics, Inc. Reports Third Quarter 2022 Financial ResultsCo-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for theRHEA-AIneutral
11/03/22 2:41 PMNasdaq : CODX conferencesCo-Diagnostics, Inc. to Host Booth at AMP This Week in Phoenix, AZCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company is hosting a booth this week at theRHEA-AIneutral
11/01/22 9:32 AMNasdaq : CODX managementCo-Diagnostics, Inc. Appoints Dr. Mark Poritz as New Chief Scientific OfficerCo-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx™" or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it is pleased to welcome Mark Poritz, PhD as theRHEA-AIvery positive
10/27/22 9:30 AMNasdaq : CODX earningsCO-DIAGNOSTICS, INC. ANNOUNCES THIRD QUARTER 2022 EARNINGS RELEASE DATE AND WEBCASTCo-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2022 results on Thursday, November 10, 2022,RHEA-AIneutral
10/26/22 9:30 AMNasdaq : CODX conferencesCo-Diagnostics, Inc. to Host Booth at Medlab Africa on Oct 26-28 in South AfricaCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week atRHEA-AIneutral
10/19/22 9:30 AMNasdaq : CODX conferencesCo-Diagnostics, Inc. to Host Booths at Conferences in Washington, D.C. and Bangkok, ThailandCo-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting booths this week atRHEA-AIneutral